SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,305,408 | -59.2% | 800,000 | -55.6% | 0.00% | -75.0% |
| Q3 2022 | $3,196,000 | +33.4% | 1,800,000 | -7.6% | 0.00% | +100.0% |
| Q2 2022 | $2,395,000 | -12.2% | 1,948,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,728,000 | +26.1% | 1,948,000 | +26.1% | 0.00% | +100.0% |
| Q4 2021 | $2,163,000 | +96.6% | 1,545,000 | +40.5% | 0.00% | 0.0% |
| Q3 2021 | $1,100,000 | +120.0% | 1,100,000 | +120.0% | 0.00% | – |
| Q2 2021 | $500,000 | -23.4% | 500,000 | 0.0% | 0.00% | – |
| Q1 2021 | $653,000 | -53.2% | 500,000 | -12.1% | 0.00% | -100.0% |
| Q4 2020 | $1,395,000 | +18.2% | 569,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,180,000 | -9.6% | 569,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,306,000 | +157.1% | 569,000 | +69.9% | 0.00% | – |
| Q1 2020 | $508,000 | -40.7% | 335,000 | -23.9% | 0.00% | -100.0% |
| Q4 2019 | $856,000 | +159.4% | 440,000 | +76.0% | 0.00% | – |
| Q3 2019 | $330,000 | -40.6% | 250,000 | 0.0% | 0.00% | – |
| Q2 2019 | $556,000 | -91.9% | 250,000 | -93.5% | 0.00% | -100.0% |
| Q1 2019 | $6,902,000 | – | 3,825,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |